Susquehanna Fundamental Investments, LLC Rigel Pharmaceuticals Inc Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.1 - $12.2 $48,780 - $541,021	-44,346 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $167,166 - $259,785	-75,300 Reduced 62.94%	44,346 $133,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $137,106 - $207,402	58,096 Added 94.39%	119,646 $317,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $145,075 - $186,525	41,450 Added 206.22%	61,550 $223,000
Q2 2021 Aug 11, 2021	BUY	$3.09 - $4.54 $62,109 - $91,254	20,100 New	20,100 $87,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.99B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.